Current Ratio of Janux Therapeutics, Inc. from 31 Mar 2022 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Janux Therapeutics, Inc. quarterly Current Ratio in % history and change rate from 31 Mar 2022 to 31 Dec 2025.
  • Janux Therapeutics, Inc. Current Ratio for the quarter ending 31 Dec 2025 was 4365%, a 18% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

Janux Therapeutics, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q4 2025 4365% -955% -18% 31 Dec 2025
Q3 2025 4824% +363% +8.1% 30 Sep 2025
Q2 2025 5072% +994% +24% 30 Jun 2025
Q1 2025 5316% +2331% +78% 31 Mar 2025
Q4 2024 5319% +3149% +145% 31 Dec 2024
Q3 2024 4462% +2433% +120% 30 Sep 2024
Q2 2024 4078% +2122% +109% 30 Jun 2024
Q1 2024 2986% +796% +36% 31 Mar 2024
Q4 2023 2170% -228% -9.5% 31 Dec 2023
Q3 2023 2028% -614% -23% 30 Sep 2023
Q2 2023 1956% -978% -33% 30 Jun 2023
Q1 2023 2189% -1062% -33% 31 Mar 2023
Q4 2022 2398% 31 Dec 2022
Q3 2022 2643% 30 Sep 2022
Q2 2022 2933% 30 Jun 2022
Q1 2022 3252% 31 Mar 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.